TEVA Pharmaceutical Industries (TEVA) shares outstanding: 1.17B
TEVA Pharmaceutical Industries had 1.17B shares outstanding on Sep 30, 2026, up 1.5% from 1.15B a year earlier.
From TEVA Pharmaceutical Industries's filings with the SEC · TEVA stock page
TEVA Pharmaceutical Industries shares outstanding by year
#85 of 3,715 US companies by shares outstanding · See the full ranking
| Year ended | Shares outstanding | Change |
|---|---|---|
| Sep 30, 2026 | 1.17B | +1% |
| Dec 31, 2025 | 1.15B | +1% |
| Dec 31, 2024 | 1.13B | +1% |
| Dec 31, 2023 | 1.12B | +1% |
| Dec 31, 2022 | 1.11B | – |
Shares outstanding of similar companies
Companies in the same industry as TEVA Pharmaceutical Industries, by SEC industry code, with the closest shares outstanding. Each name opens the same page for that company.
| Company | Shares outstanding, latest year | Year ended |
|---|---|---|
| Abbott Laboratories | 1.73B | Sep 30, 2026 |
| BeOne Medicines | 1.48B | Oct 30, 2026 |
| TEVA Pharmaceutical Industries | 1.17B | Sep 30, 2026 |
| Viatris | 1.15B | Nov 2, 2026 |
| Eli Lilly | 940.7M | Oct 26, 2026 |
| HUTCHMED (China) | 872.3M | Dec 31, 2025 |
| Summit Therapeutics | 799.8M | Oct 30, 2026 |
Questions and answers
What is TEVA Pharmaceutical Industries's shares outstanding?
TEVA Pharmaceutical Industries had 1.17B shares outstanding on Sep 30, 2026, up 1.5% from 1.15B a year earlier.
Numbers as reported in TEVA Pharmaceutical Industries's annual and quarterly reports to the SEC (XBRL data). A year is the company's fiscal year that falls mostly in that calendar year; balances such as cash and debt are as of the date shown. Data only, not investment advice. Methodology